Polypharmacy as the initial second-generation antipsychotic treatment

Psychiatric Services

Volumn 59, Issue 7, 2008, Pages 717-

  Lee, Brason ^a   Walker, Victor ^b  

^a Center for Family Health   (United States)

^b California Department of Health Care Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; AMBULATORY CARE; ARTICLE; DATA ANALYSIS; FEMALE; HUMAN; MALE; MEDICAID; MEDICAL PRACTICE; PHARMACEUTICAL CARE; PHYSICIAN; POLYPHARMACY; PRESCRIPTION;

ANTIPSYCHOTIC AGENTS; CALIFORNIA; HUMANS; MEDICAID; POLYPHARMACY; SCHIZOPHRENIA; UNITED STATES;

EID: 49949107201     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.59.7.717     Document Type: Article

References (3)

1. Botts S, Hines H, Littrell R: Antipsychotic polypharmacy in the ambulatory care setting, 1993-2000. Psychiatric Services 54:8, 2003
2. Stahl SM: Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials. Journal of Clinical Psychiatry 60:31-41, 1999
3. Aparasu R, Bhatara V, Gupta S: US national trends in the use of antipsychotics during office visits, 1998-2002. Annals of Clinical Psychiatry 17:147-152, 2005